Cargando…
Nebulized tranexamic acid for recurring hemoptysis in critically ill patients: case series
BACKGROUND: Hemoptysis is a clinical condition encountered in the emergency department (ED) and must be managed and investigated urgently to maintain the patient’s hemostasis. The management of hemoptysis depends on treating the underlying cause. Tranexamic acid (TXA) is an anti-fibrinolytic drug us...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439666/ https://www.ncbi.nlm.nih.gov/pubmed/32819268 http://dx.doi.org/10.1186/s12245-020-00304-x |